Clinical Trial Update: Evaluation of Low Dose Corticosteroids Efficiency, Associated With Myfortic ® in the Treatment of Nephrotic Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating low-dose corticosteroids in combination with Myfortic for nephrotic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrotic Syndrome

Drugs mentioned

• MYFORTIC (MYCOPHENOLIC ACID)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Nephrotic Syndrome | Phase 3 | Status: COMPLETED